Stock listing

NASDAQ:ESPR Esperion Therapeutics, Inc. Stock

Home listing (NASDAQ) of Esperion Therapeutics, Inc.

Follow Esperion Therapeutics, Inc. into a list and get an email when it puts out news.

Esperion Therapeutics, Inc. logo
Ticker
NASDAQ:ESPR
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Esperion Therapeutics (NASDAQ:ESPR) Q4 2025 Earnings Call

    Tue, Mar 10, 2026 · 8:00 AM ET

    Watch Transcript

  • Esperion Therapeutics (NASDAQ:ESPR) Q3 2025 Earnings Call

    Thu, Nov 06, 2025 · 8:00 AM ET

    Watch Transcript

  • Esperion Therapeutics (NASDAQ:ESPR) Q2 2025 Earnings Call

    Tue, Aug 05, 2025 · 8:00 AM ET

    Watch Transcript

Latest news

Esperion Therapeutics Offers Short-Term Option for Diuretic Management Before Escalation to IV for Patients With Heart Failure

Sep 30, 2026

Esperion Presents New Data from CLEAR Outcomes and the CLEAR PATH Phase 2 Pediatric Study at the European Atherosclerosis Society Congress 2026

May 26, 2026

Esperion Announces Two New Analyses Supporting Bempedoic Acid to Reduce LDL-C Levels to be Presented at the European Atherosclerosis Society (EAS) Congress 2026

May 13, 2026

Esperion to be Acquired by ARCHIMED

May 1, 2026

Esperion to Report First Quarter 2026 Financial Results on May 7

Apr 23, 2026

Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

Apr 2, 2026

Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics

Apr 2, 2026

Esperion to Participate in 25th Annual Needham Virtual Healthcare Conference

Mar 31, 2026

Esperion Showcases New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) at the American College of Cardiology’s Annual Scientific Session 2026

Mar 30, 2026

Esperion to Present Two New Analyses from CLEAR Outcomes Clinical Trial at the American College of Cardiology 2026 Annual Scientific Session

Mar 17, 2026

All Esperion Therapeutics, Inc. news

Decks

Esperion Therapeutics, Inc. on 6ix

News releases
29 in the last 12 months · 181 in all · newest Sep 30, 2026 · oldest 2019
Calls
21 calls with a replay · 21 with a transcript · latest Mar 10, 2026
Decks
7 decks · latest Mar 10, 2026

Where Esperion Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ESPR · Home listing · This pageNASDAQUnited StatesUSD
LSE:0IIMLSEUnited KingdomUSD
gettex:0ETgettexGermanyEUR
Tradegate:0ETTradegateGermanyEUR
Stuttgart:0ETStuttgartGermanyEUR
BOATS:ESPRBOATSUnited StatesUSD
LS Exchange:A1W1SJLS ExchangeGermanyEUR
Lang & Schwarz:A1W1SJLang & SchwarzGermanyEUR
BX Swiss:0ETBX SwissSwitzerlandCHF
Frankfurt:0ETFrankfurtGermanyEUR
Dusseldorf:0ETDusseldorfGermanyEUR
Munich:0ETMunichGermanyEUR

Log in to ask 6ix AI your own questions about Esperion Therapeutics, Inc.